Myriad Genetics | MYGN - Capital Ordinaire





Capital Ordinaire Changement Date
Agilent USD 282.22M 478K 2026-03
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Bruker USD 152.35M 130K 2026-06
Danaher USD 702.9M 4.8M 2026-06
Illumina USD 151.3M 607K 2026-06
J&J USD 2.41B 1.35M 2026-03
Mettler Toledo International USD 20.21M 40.9K 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quest Diagnostics USD 110M 1000K 2026-06
Quidel USD 68.1M 200K 2026-03
Repligen USD 56.43M 28K 2026-06
Revvity USD 111.63M 174K 2026-06
Standard Biotools USD 390.14M 3.76M 2026-03
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Veracyte USD 79.79M 1000 2026-06
Waters USD 98.19M 20K 2026-06